Exclusive Speaker Interview with Achim Kless, Pain Genetics Lead from Eli Lilly & Company ahead of Pain Therapeutics Read more
Celcuity Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Gedatolisib Read more
Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients Read more
Context Therapeutics and Integral Molecular Enter Collaboration and License Deal for Novel Claudin 6 Antibodies for Gynecologic Cancer Therapeutic Program Read more
AbbVie Submits Regulatory Applications for SKYRIZI (risankizumab) in Psoriatic Arthritis to FDA and EMA Read more
Icosavax Closes $100 Million Series B Financing to Advance Bivalent RSV/hMPV Vaccine Candidate Into Clinical Trials Read more
CytoDyn Signs Exclusive Supply and Distribution Agreement with Biomm S.A. in Brazil for COVID-19 and All Other Leronlimab Indications Read more
FDA Keynote Speakers at SMi’s 4th Annual Pharmaceutical Microbiology East Coast Virtual Conference in 3 weeks Read more
AIM ImmunoTech Announces Positive Safety Data in First Cohort of Phase 1 Clinical Study Investigating Intranasal Administration of Ampligen as a Potential Prophylaxis or Treatment for COVID-19 and Other Respiratory Viral Diseases Read more
AB Science announces the signing of an exclusive licensing agreement with the University of Chicago to conduct research for the prevention and treatment of Covid-19 Read more